Bellevue Life Sciences Acquisition (NASDAQ:BLAC) Stock Price Up 0.7% – Still a Buy?

Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLACGet Free Report) shot up 0.7% during trading on Friday . The stock traded as high as $0.4659 and last traded at $0.4410. 174,571 shares changed hands during trading, an increase of 672% from the average session volume of 22,626 shares. The stock had previously closed at $0.4378.

Bellevue Life Sciences Acquisition Stock Up 0.7%

The company’s fifty day moving average price is $0.60 and its 200-day moving average price is $0.62.

About Bellevue Life Sciences Acquisition

(Get Free Report)

Bellevue Life Sciences Acquisition Corp. (NASDAQ: BLAC) is a special purpose acquisition company organized as a Delaware corporation. The company completed its initial public offering in 2021, raising gross proceeds to pursue a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more life sciences businesses.

BLAC’s principal activity is to identify and complete a business combination with a target operating company in the life sciences sector.

Further Reading

Receive News & Ratings for Bellevue Life Sciences Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellevue Life Sciences Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.